皇冠体育信用（www.hg9988.vip）是一个开放皇冠网址即时比分、皇冠网址代理最新登录线路、皇冠网址会员最新登录线路、皇冠网址代理APP下载、皇冠网址会员APP下载、皇冠网址线路APP下载、皇冠网址电脑版下载、皇冠网址手机版下载、皇冠体育信用官方平台。

KUALA LUMPUR: Ace-Market bound UMediC Group Bhd’s public portion of its initial public offering (IPO) has been oversubscribed by 46.81 times.

The medical device manufacturer, in a statement, said a total of 7,888 applications for 893.92 million IPO shares from the Malaysian public, representing an oversubscription rate of 46.81 times.

“A total of 3,998 applications for 321.93 million IPO shares were received under the Bumiputera category, representing an oversubscription rate of 33.44 times, whilst 3,890 applications for 571.98 million IPO Shares were received under the other Malaysian public category, representing an oversubscription rate of 60.19 times,” it said.

皇冠买球网（www.hg108.vip）是皇冠体育官网线上直营平台。皇冠买球网面向亚太地区招募代理，开放皇冠信用网代理申请、皇冠现金网代理会员开户等业务。皇冠买球网可下载皇冠官方APP，皇冠买球网APP包括皇冠体育最新代理登录线路、皇冠体育最新会员登录线路。

Meanwhile, UMediC said the 13.09 million new shares it allocated for subscription by eligible directors, employees and persons who have contributed to the success of the group have been fully subscribed.

The sole placement agent, Affin Hwang Investment Bank Bhd, has confirmed that the 65.44 million IPO shares made available for application by way of private placement to selected investors have been fully placed.

Affin is the principal adviser, sponsor, sole placement agent, and sole underwriter for the IPO exercise.

UMediC, which is expected to be listed on Bursa Malaysia’s ACE Market on July 26, aims to raise RM31.1mil from its IPO.